Full name
CENTRALNE LABORATORIUM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.90.E - Other human health activities notelsewhere classified
46.19.Z - Agents involved in the sale of a variety of goods
46.46.Z - Wholesale of pharmaceutical goods
46.90.Z - Non-specialised wholesale trade
71.20.A - Food quality testing and analysis
71.20.B - Other technical testing and analysis
72.19.Z - Other research and experimental development on natural sciences and engineering
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
85.59.B - Other out-of-school forms of education, not elsewhere classified
85.60.Z - Educational support activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,1 | -0,2 | 0,1 | 134,3 |
EBITDA | 0,2 | -0,1 | 0,1 | 215,3 |
Short time liabilities | 0,2 | 0,3 | 0,4 | 31,4 |
Equity capital | 0,2 | -0 | 0 | 116,4 |
Operating profit (EBIT) | 0,1 | -0,2 | 0,1 | 134,6 |
Assets | 0,4 | 0,2 | 0,4 | 57,2 |
Net profit (loss) | 0,1 | -0,2 | 0,1 | 134,3 |
Cash | 0 | 0 | 0 | -24,2 |
Net income from sale | 2,1 | 2,1 | 2,7 | 24,9 |
Liabilities and provisions for liabilities | 0,2 | 0,3 | 0,4 | 28,9 |
Working assets | 0,2 | 0,2 | 0,2 | 14 |
Depreciation | 0,1 | 0,1 | 0,1 | -3,8 |
% | % | % | p.p. | |
Profitability of capital | 46,1 | 339,4 | 710,1 | 370,7 |
Equity capital to total assets | 50,4 | -19,5 | 2 | 21,5 |
Gross profit margin | 4,3 | -7,5 | 2,1 | 9,6 |
EBITDA Margin | 7,3 | -4,6 | 4,3 | 8,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 31 | 48 | 51 | 3 |
Current financial liquidity indicator | 1.3762413263320923 | 0.5597922801971436 | 0.4855425953865051 | -0,1 |
Net dept to EBITDA | -0.12867210805416107 | 0.2582179307937622 | -0.2066907286643982 | -0,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane